Acute onset quadriparesis following oesophagectomy due to isolated hypophosphataemia
Sir,
A 65-year-old male weighing 50 kg with carcinoma oesophagus received neo-adjuvant chemotherapy (carboplatin and paclitaxel) and radiation and subsequently underwent transhiatal oesophagectomy under general anaesthesia after an elaborate preoperative workup which was unremarkable. His past medical and surgical history was unremarkable. All preoperative laboratory investigations including electrolytes were within normal limits. At the end of surgery, the patient was shifted to the surgical intensive care unit and the trachea was extubated uneventfully after 2 h. On postoperative day (POD) 2, high flow oxygen therapy was initiated via nasal cannula as he developed bibasal atelectasis, had poor incentive spirometry efforts and had a PaO 2 /FiO 2 ratio of 175. On POD3, he developed sudden onset atrial fibrillation (AF) with fast ventricular rate which was managed with IV amiodarone. About 24 h after new onset AF, patient developed acute onset flaccid quadriparesis which raised a suspicion of thromboembolic phenomenon. This was ruled out on echocardiography (right heart function and chambers were normal with normal biventricular function) and a normal computed tomography scan of brain. Meanwhile, sample for serum electrolytes (sodium, potassium, chloride, calcium, magnesium and phosphate) was sent. Serum phosphate was 1.7 mg/dl (normal range 2.5-4.5 mg/dl), which was very low. Correction with intravenous injection Potphos™ (93 mg/ml of phosphorus and 170 mg/ml of potassium chloride) available as 15 ml vial (manufactured by Neon Laboratories Ltd.) was started. Values of other electrolytes were within normal limits. The acute onset quadriparesis recovered in 45 min of starting phosphorus correction. The patient was thereafter treated with IV Potphos™ 1 vial/day for 3 days and was later on advised to use Addphos™ sachet (available as 3.2 g sachet, manufactured by Steadfast Medishield Pvt. Ltd.), which contains 1.936 g of sodium acid phosphate, for 2 weeks. He was transferred to ward on POD 8. Serum phosphorus level measured prior to discharge was 3.5 mg/dl which was considered within normal range.
There could be numerous causes of hypophosphataemia in post-oesophagectomy patients. Prolonged use of antacids, poor nutritional status, re-feeding syndrome, acute respiratory alkalosis, and bronchodilator use can all contribute to hypophosphatemia in the early postoperative period. [1] Severe hypophosphataemia has been demonstrated as a rare cause of early postoperative weakness. [2] It is a documented complication after hepatic surgery with multifactorial cause including increased excretion in urine due to phosphatonins. [3] To the best of our knowledge, similar acute onset symptoms of hypophosphataemia have not been described after oesophagectomy. We suggest monitoring phosphate levels in the early postoperative period for oesophagectomy patients. As suggested by Ianov et al., [4] phosphorus correction should be done slowly at the rate of 10-45 mmol in 6-8 h (10 mmol = 1395 mg phosphorus which is present in 15 ml of potassium phosphate infusion). Indian Journal of Anaesthesia | Volume 63 | Issue 6 | June 2019
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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Long-term anticoagulation is required in patients with artificial heart valves to avoid thromboembolic complications. In such cases, a target international normalised ratio (INR) has to be maintained for anticoagulation to prevent thromboembolism which needs to be balanced carefully to avoid haemorrhagic complications, owing to narrow therapeutic index of vitamin K antagonists. [1, 2] There is a lot of controversy and ambiguity regarding the type of treatment required to reverse anticoagulation for emergency surgery and the ideal time to restart anticoagulation therapy safely. [1] [2] [3] A 22-year-old female presented with abdominal pain since one day with a history of open heart surgery seven months back (mitral valve replacement: TTK ® 25mm Chitra heart valve prosthesis). She was taking oral warfarin 5 mg once daily with an INR of 2.7 which was done 2 months back. On examination, there was low volume pulse rate of 116/min, noninvasive blood pressure of 96/50 mmHg and respiratory rate of 22/min with a SpO 2 of 96% on room air. She was anxious but alert and oriented. She was resuscitated with 1 L of crystalloids till her vitals were relatively stable. Bedside ultrasonography was suggestive of gross ascites and free floating shadows suspected due to a haemorrhagic right ovarian cyst and she was planned for an emergency laparotomy.
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